Work

How is subcutaneous depot buprenorphine used to treat opioid use disorder in patients with pyloric stenosis?

Year: 2026

Type: article

Abstract: No direct evidence for the use of subcutaneous depot buprenorphine in patients with pyloric stenosis for opioid use disorder was identified. However, subcutaneous administration may be advantageous by avoiding gastrointestinal complications associated with pyloric stenosis.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.24056642

Author: Tripdatabase

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7225582972

FWCI:

Cites:

Cited by:

Related to: 10